A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]
<p>Abstract</p> <p>Background</p> <p>Although much has been written about the influence of local opinion leaders on clinical practice, there have been few controlled studies of their effect, and almost none have attempted to change prescribing in the community for chron...
Main Authors: | Tsuyuki Ross T, McAlister Finlay A, Majumdar Sumit R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-06-01
|
Series: | BMC Cardiovascular Disorders |
Online Access: | http://www.biomedcentral.com/1471-2261/5/17 |
Similar Items
-
A randomized trial to assess the impact of opinion leader endorsed evidence summaries on the use of secondary prevention strategies in patients with coronary artery disease: the ESP-CAD trial protocol [NCT00175240]
by: Ghali William A, et al.
Published: (2006-05-01) -
LEADER ENDORSEMENT: THE ROLE OF LEADER PROTOTYPICALITY, LEADER EFFECTIVENESS AND EMPLOYEE’S ORGANIZATIONAL IDENTIFICATION
by: Taufik Nur Rochman, et al.
Published: (2020-09-01) -
The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788]
by: Tsuyuki Ross, et al.
Published: (2010-04-01) -
Improving hypertension management through pharmacist prescribing; the rural alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods
by: Campbell Norman RC, et al.
Published: (2011-08-01) -
Frequency and Type of Outpatient Visits for Patients With Cardiovascular Ambulatory‐Care Sensitive Conditions During the COVID‐19 Pandemic and Subsequent Outcomes: A Retrospective Cohort Study
by: Finlay A. McAlister, et al.
Published: (2023-02-01)